Author:
Devanath Anitha,Ray Somdattaa,Kumar Ravi,Prarthana B. S.
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853–60.
2. Kingsley L, Smit E, Riddler S, Li R, Chmiel J, Palella F, et al. Prevalence of lipodystrophy and metabolic abnormalities in the Multicenter AIDS Cohort Study (MACS) [Abstract 538]. Program and Abstracts of the 8th Conference on Retroviruses and Opportunistic Infections. Chicago, IL: 2001. Feb 4–8.
3. Stein JH, Klein MA, Bellehumeur JL, McBride PE, Wiebe DA, Otvos JD, et al. Use of Human Immunodeficiency Virus-1 Protease Inhibitors is Associated With Atherogenic Lipoprotein Changes and Endothelial Dysfunction. Circulation. 2001;104:257–64.
4. Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS. 1998;12(7):F51–8.
5. Périard D, Telenti A, Sudre P, Cheseaux JJ, Halfon P, Reymond MJ, et al. For the Swiss HIV Cohort Study. Atherogenic Dyslipidemia in HIV-Infected Individuals Treated With Protease Inhibitors. Circulation. 1999;100:700–5.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献